Last reviewed · How we verify

Cholecalciferol (vitamin D)

University of Tromso · FDA-approved active Small molecule

Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.

Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function. Used for Vitamin D deficiency, Osteoporosis and bone health maintenance, Hypocalcemia.

At a glance

Generic nameCholecalciferol (vitamin D)
Also known asvitamin D
SponsorUniversity of Tromso
Drug classVitamin D supplement / Secosteroid
TargetVitamin D receptor (VDR)
ModalitySmall molecule
Therapeutic areaNutritional supplementation / Bone health / Immunology
PhaseFDA-approved

Mechanism of action

Cholecalciferol is a fat-soluble vitamin that undergoes hydroxylation in the liver to 25-hydroxyvitamin D, then in the kidneys to the active hormone 1,25-dihydroxyvitamin D (calcitriol). The active form binds to the vitamin D receptor (VDR) in target tissues, regulating intestinal calcium absorption, bone mineralization, and immune cell differentiation and function.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: